Interleukin-23 Antagonist
- Name
- Interleukin-23 Antagonist
- Accession Number
- DBCAT003460 (DBCAT004306)
- Description
Not Available
- Drugs
Drug Drug Description Ustekinumab A targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. Guselkumab A monoclonal antibody used to treat moderate to severe plaque psoriasis. Tildrakizumab An interleukin-23 antagonist used to treat moderate to severe plaque psoriasis. Risankizumab An interleukin-23 antagonist used to treat plaque psoriasis, psoriatic arthritis, and Crohn's disease in adults. Mirikizumab An anti-IL-23 monoclonal antibody used as a second-line therapy for moderate-to-severe active ulcerative colitis. - Drugs & Drug Targets